Skip to main content

Find Clinical Trials

Home
Conditions
Tumor Virus Infections

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies

Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Completed

Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies

NCT04191187

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +56 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

NCT04157985

Conditions: Adenocarcinoma, Advanced Solid Tumors, Anal Cancer, +69 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Environmental Risk Factors in Multiple Sclerosis Development: Epidemiological Study of EBV Infection and Vitamin D Deficiency in RIS Patients

NCT07256431

Conditions: DNA Virus Infections, Epstein-Barr Virus Infections, Herpesviridae Infections, +4 more
Locations: CHU de Nîmes Nîmes, France

View Trial Details

Completed

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

NCT02568553

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +53 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

View all 24 locations

View Trial Details

Completed

Veliparib and Temozolomide in Treating Patients With Acute Leukemia

NCT01139970

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +45 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States

Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients

NCT04189835

Conditions: DNA Virus Infections, EBV Infection, EBV Viremia, +7 more
Locations: Aarhus University Hospital Aarhus, Central Region Denmark, Denmark

Odense University Hospital Odense, Region Syddanmark, Denmark

Rikshospitalet, Oslo Universitetssykehus Oslo, Norway

View Trial Details

Completed

DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections

NCT05509413

Conditions: Cervix Dysplasia, Communicable Diseases, DNA Virus Infections, +20 more
Locations: Marien Hospital Herne Herne, North Rhine-Westphalia, Germany

View Trial Details

Completed

Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine

NCT02996773

Conditions: Actinomycetales Infections, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +52 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts

NCT03160079

Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations: UCSF Fresno Community Cancer Institute Clovis, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States

UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab

NCT03480438

Conditions: B-precursor ALL, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany

Uniklinik RWTH Aachen Aachen, Germany

Charité - Campus Benjamin Franklin Berlin, Germany

Vivantes Klinikum Neukölln Berlin, Germany

View all 21 locations

View Trial Details